Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from Archer Materials ( (AU:AXE) ) is now available.
Archer Materials has entered a partnership with Paragraf Limited to advance the development of its Biochip for at-home testing of chronic kidney disease. This collaboration aims to enhance the technical progress of Archer’s blood potassium sensor, focusing on improving sensor accuracy, stability, and robustness. The partnership is expected to generate intellectual property for Archer, strengthening its position in the medical diagnostics industry and supporting future product development and clinical trials.
More about Archer Materials
Archer Materials is a technology company operating in the semiconductor industry, focusing on the development of advanced semiconductor devices for quantum computing, sensing, and medical diagnostics. The company leverages global partnerships to enhance its technology for potential applications across various industries.
YTD Price Performance: -56.90%
Average Trading Volume: 218,243
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$63.71M
See more data about AXE stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue